PIPELINE
파이프라인
파이프라인 개발 전략
- 1단계: Best-in-Class
- 2단계: First-in-Class
Project
Indication
Hit
Lead
Candidate
Preclinical
Phase I
TRX-221
EGFR+ NSCLC
IBC-1131
Solid tumors
TRX-211
EGFR+ NSCLC
TRX-212
Lymphoma
TRX-215
Undisclosed
TRX-214
Undisclosed